Respiratory Failure Deaths With Atrial Fibrillation Climbed Sharply in Older Adults
Mortality tied to respiratory failure with co-listed atrial fibrillation/flutter rose steeply among U.S. adults aged 65 years and older between 1999 and 2024, reaching a level far above the baseline seen at the start of the period. The analysis, built from CDC WONDER multiple-cause-of-death data, captured 433,598 deaths in which both conditions appeared together on the death certificate. The overall age-adjusted mortality rate increased from 12.8 per 100,000 in 1999 to 66.7 per 100,000 in 2024, a pattern that points to a growing burden of cardiorespiratory instability in an aging population.
The trajectory was not smooth. Three distinct phases emerged: a steady climb from 1999 through 2018, a much sharper rise from 2018 through 2021, and a decline from 2021 through 2024 that did not erase the earlier gains in mortality.
The Pandemic-Era Spike Changed the Shape of the Curve
The most abrupt acceleration came during the 2018 to 2021 interval, when the annual percent change reached 18.10%. In practical terms, this is the kind of inflection that often follows severe strain on health systems, worsening frailty in older adults, and destabilization of chronic cardiovascular and pulmonary disease. Respiratory failure rarely acts alone in that setting; once atrial fibrillation enters the picture, cardiac output can fall, pulmonary congestion can worsen, and the margin for physiologic reserve narrows quickly.
By 2024, the age-adjusted mortality rate had reached 66.7 per 100,000, and the average annual percent increase across the full study period was 8.11% overall. The pattern is consistent with a long-running rise in dual cardiorespiratory vulnerability, with a temporary surge that became especially pronounced during the COVID-19 era.
Men Carried a Higher Mortality Burden Than Women
Sex-based differences were persistent. Men had a higher age-adjusted mortality rate than women and also a steeper rise over time, with average annual percent changes of 8.44% versus 7.81%, respectively. The gap suggests more than a numerical difference in death rates; it signals distinct underlying risk burdens, including differing prevalence of cardiopulmonary disease, comorbidity patterns, and healthcare use later in life.
A single sentence captures the clinical pressure behind the statistics: once respiratory failure and atrial arrhythmia converge in frail older adults, deterioration can become rapid.
Racial and Ethnic Patterns Point to Uneven Risk
Non-Hispanic White adults had the highest mean age-adjusted mortality rate across the study period, yet the fastest relative increase appeared among Hispanic adults, whose average annual percent change reached 8.72%. Non-Hispanic Asian/Pacific Islander adults had the smallest increase, at 6.23%. These differences do not reduce to one mechanism. They likely reflect a mixture of disease prevalence, access to care, timing of diagnosis, treatment intensity, and social determinants that shape survival in chronic cardiovascular and respiratory illness.
The finding with the largest relative rise matters because it suggests a shifting burden, not a static one. Mortality inequalities in older adults can widen even when one group starts from a lower baseline, especially when cardiopulmonary disease is compounded by delayed access to coordinated care.
Regional and Geographic Differences Were Wide
The Midwest experienced the fastest regional growth, with an average annual percent change of 9.35%. Non-metropolitan areas also climbed faster than metropolitan areas from 1999 to 2020, with annual percent changes of 10.09% and 8.21%, respectively. Rural and semi-rural settings often face longer transport times, fewer subspecialty resources, and slower access to advanced rhythm management or respiratory support, all of which can influence outcomes when serious decompensation occurs.
State-level variation was substantial. Mortality ranged from 24.7 per 100,000 in Ohio to 85.1 per 100,000 in Louisiana. Such a spread argues for local differences in disease burden, healthcare infrastructure, and population health, rather than a single national pattern that behaves uniformly across states.
Most Deaths Occurred in Hospitals, But Long-Term Care Carried a Large Share
Hospital inpatient settings accounted for 64.1% of deaths, followed by nursing homes at 14.1% and home deaths at 11.9%. This distribution reflects the acuity of the combined syndrome. Respiratory failure severe enough to appear on a death certificate alongside atrial fibrillation/flutter often requires inpatient management because oxygenation, fluid balance, hemodynamics, and rhythm instability can all deteriorate at once.
Nursing home deaths deserve attention as well. Older adults in long-term care often have advanced frailty, cognitive impairment, and multiple chronic diseases, all of which can blunt the response to acute respiratory or cardiac worsening.
Forecasts Suggest Mortality Could Keep Rising Through 2035
The projection model estimated that the age-adjusted mortality rate will reach 122.96 per 100,000 by 2035, with a 95% prediction interval of 85.42 to 160.50. Forecasting is not destiny, but the direction of travel is hard to ignore. If the underlying drivers remain unchanged, older adults with overlapping respiratory and rhythm disease could account for an even larger share of mortality in the next decade.
The study used an exponential smoothing model, which is designed to project future values based on observed time trends rather than to prove causation. Even so, the forecast reinforces the scale of the observed increase and suggests that the post-2021 decline has not yet restored mortality to earlier levels.
Coordinated Cardiopulmonary Care Emerges as the Core Clinical Need
The data support a simple but consequential interpretation: older adults with both respiratory failure and atrial fibrillation/flutter represent a high-risk group that may benefit from earlier recognition and tighter coordination between cardiovascular and pulmonary care. Atrial fibrillation can worsen filling pressures, promote hemodynamic instability, and reduce effective cardiac output. Respiratory failure can intensify sympathetic stress and hypoxemia, both of which can aggravate arrhythmia burden. In combination, the two conditions can reinforce each other in a downward spiral.
Because the analysis is based on death certificate coding, it cannot distinguish which condition came first, how much disease severity each contributed, or whether specific treatments altered survival. It also cannot capture the full clinical context behind each death. Even with those limits, the pattern remains stark: mortality has risen more than fivefold over 25 years, surged during the COVID-19 period, and now shows persistent disparities by sex, race and ethnicity, geography, and place of death.